3.4. Whole-Exosome Sequencing of Endometrial Tumors with POLD1 p.D402N Mutation Revealed POLD1 DNA Proofreading Deficiency-Specific Mutational Signature and a Pan-Tumor Genomic Biomarker for Immunotherapy. The gene discussed is POLD1; the disease is endometrium neoplasm.